Critical care

Hoag Receives $15 Million Gift from Philanthropists Julia and George Argyros at 2024 Nurse of the Year Celebration

Retrieved on: 
fredag, maj 3, 2024
Magnet, Education, Cancer, Critical care, MSN, BSN, Hospital, Dream, Health, Heart, ANCC, Diabetes, Vanguard University, Culture, Certification, Patient, Argyros, RN, Sub, Evidence-based practice, Nursing

The generous gift brings the Argyros family's cumulative giving to Hoag to over $32 million, which has provided thousands of scholarships to Hoag nurses.

Key Points: 
  • The generous gift brings the Argyros family's cumulative giving to Hoag to over $32 million, which has provided thousands of scholarships to Hoag nurses.
  • This latest gift by the Argyros family builds upon their ongoing generous philanthropy directed to Hoag's nursing.
  • In 2016, Hoag established the Julia Argyros Center for Nursing Excellence in recognition of the family's dedication.
  • We want to thank Julia, George, Lisa and Stephanie Argyros for their overwhelming generosity, along with many other donors.

Cytovale's Diagnostic Test Demonstrates Strong Performance in Rapid Identification of Sepsis Risk, Peer-Review Study Confirms

Retrieved on: 
torsdag, maj 2, 2024
Septic, Emergency department, FDA, Academic Emergency Medicine, Critical care, Risk, Hospital, Food, Research, Triage, Length of stay, Pulmonary embolism, Patient, EDS, Hospice and palliative medicine, Medical director, ED, Food and Drug Administration, SAN, Sepsis, Infection, Nursing

SAN FRANCISCO, May 2, 2024 /PRNewswire/ -- Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced the publication of a new peer reviewed-study in "Academic Emergency Medicine'' that demonstrates strong diagnostic performance of the company's IntelliSep® host response test for sepsis detection. The study analyzed 1,002 patients and evaluated the accuracy of IntelliSep to rapidly diagnose patients with sepsis and help clinicians expedite appropriate care.

Key Points: 
  • The study analyzed 1,002 patients and evaluated the accuracy of IntelliSep to rapidly diagnose patients with sepsis and help clinicians expedite appropriate care.
  • The test provides critical new information about immune activation and sepsis risk stratification through a simple blood draw in about 8 minutes.
  • IntelliSep was evaluated for accurately diagnosing sepsis and providing a rapid, objective tool for determining the risk and severity of sepsis in these patients.
  • The test showed similar 'rule-in' performance to other critical ED tests, with a Positive Predictive Value of 55%.

The Inner Circle acknowledges Mary J. Aloia-Dombrowski as a Pinnacle Professional Lifetime Member

Retrieved on: 
måndag, april 29, 2024
Education, Oncology, Critical care, Palliative care, JFK Medical Center, Terminal, Travel, Hospice, State university system, Mentorship, American Journal, Death, American Cancer Society, Parent, National Association, Clinical Social Work Journal, Friends, Master, Golf, Patient, MRMC, Pinnacle, Multimedia, Philosophy, Good, Stockton University, Inner circle, Journal, Muhlenberg Regional Medical Center, Nursing

PLAINFIELD, N.J., April 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary J. Aloia-Dombrowski is acknowledged as a Pinnacle Professional Lifetime Member for her contributions to Hospice Social Work.

Key Points: 
  • PLAINFIELD, N.J., April 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary J. Aloia-Dombrowski is acknowledged as a Pinnacle Professional Lifetime Member for her contributions to Hospice Social Work.
  • Ms. Aloia-Dombrowski is a highly respected hospice social worker currently working at Hackensack Meridian Health Hospice.
  • She enjoys reading the Journal of Social Work, Clinical Social Work Journal, and American Journal of Hospice and Palliative Medicine.
  • The most important days of your life are the day you were born and the day you figure out why."

Huize Partners with Ruihua Health Assurance to Launch “Darwin Critical Care No.9” – A Customized Critical Illness Insurance Product

Retrieved on: 
måndag, april 15, 2024
Critical care, Insurance, RMB, Cancer, Diagnosis

SHENZHEN, China, April 15, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China, today announced that it has partnered with Ruihua Health Assurance Corporation (“Ruihua Health Assurance”) to launch “Darwin Critical Care No.9”, the latest customized critical illness insurance product in the “Darwin Critical Care” series, which was first launched in 2018.

Key Points: 
  • SHENZHEN, China, April 15, 2024 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data-driven and AI-powered solutions in China, today announced that it has partnered with Ruihua Health Assurance Corporation (“Ruihua Health Assurance”) to launch “Darwin Critical Care No.9”, the latest customized critical illness insurance product in the “Darwin Critical Care” series, which was first launched in 2018.
  • Mr. Cunjun Ma, Founder, Chairman, and Chief Executive Officer of Huize, commented, “We are excited to present the latest addition to our successful produce series, ‘Darwin Critical Care Series’.
  • In this new product, we introduced another innovative and cost-effective feature: additional benefit payouts upon the first diagnosis of a severe illness, equivalent to the sum of premiums paid.
  • This new feature offers enhanced and comprehensive coverage for our customers and reflects our strident commitment to meeting their needs.

28 Leading Brands Unveil Exclusive Discounts for National Nurses Week

Retrieved on: 
torsdag, maj 2, 2024
Nursing, Data Management, Online Retail, Technology, Health, Fashion, Security, Cosmetics, Retail, Software, Home Goods, Tiny Love, Clinique, Maytag, CMO, PLUS, Critical care, L.L.Bean, THANK, KitchenAid, Safety, Skin, Travel, Codecademy, Commerce, Health care, Aveda, Ashley Furniture Industries, Military personnel, UGG, Dorel Industries, Alterra Mountain Company, MAC, Holland America Line, MAC Cosmetics, Purple, Health professional, The North Face, Tarte Cosmetics, Student, Evenflo

In an ongoing effort to honor the critical contributions of healthcare professionals, SheerID, the global leader in identity verification for commerce, has once again partnered with 28 leading brands to provide exclusive discounts during National Nurses Week.

Key Points: 
  • In an ongoing effort to honor the critical contributions of healthcare professionals, SheerID, the global leader in identity verification for commerce, has once again partnered with 28 leading brands to provide exclusive discounts during National Nurses Week.
  • “SheerID is delighted to continue our partnerships with brands that understand the importance of these frontline healthcare professionals,” expressed Sai Koppala, CMO of SheerID.
  • Burton Snowboards : Nurses can score up to 50% off select softgoods and up to 40% select hardgoods.
  • tarte cosmetics : tarte cosmetics honors healthcare heroes with an exclusive 40% discount on all products on tarte.com, year-round.

Edwards Lifesciences Reports First Quarter Results

Retrieved on: 
torsdag, april 25, 2024
Managed Care, Biotechnology, Health, Cardiology, Acumen, Mortality, FDA, Critical care, Investment, Pulmonary artery catheter, Research, Trial of the century, Aortic stenosis, Growth, Ultra, U.S. FDA, ICU, TAVR, Patient, PROGRESS, EPS, Hospital, PASCAL, Quality of life, M3, Heart failure, Pharmaceutical industry

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024.

Key Points: 
  • Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2024.
  • Surgical Structural Heart sales for the quarter were $266 million, which grew 7%, or 8% on a constant currency basis.
  • For the quarter, the adjusted gross profit margin was 76.0%, compared to 77.5% in the same period last year.
  • For the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion, and adjusted EPS of $0.67 to $0.71.

American Association of Critical-care Nurses Publishes Specialty's First Standards for Appropriate Staffing

Retrieved on: 
onsdag, april 24, 2024
Critical care, Partner, Hospital, Publication, Health, Nursing, Patient safety, Patient, AACN, Appropriation, HWE

ALISO VIEJO, Calif., April 24, 2024 /PRNewswire/ -- The American Association of Critical-Care Nurses (AACN) has published "AACN Standards for Appropriate Staffing in Adult Critical Care," the specialty's first, action-oriented staffing standards.

Key Points: 
  • ALISO VIEJO, Calif., April 24, 2024 /PRNewswire/ -- The American Association of Critical-Care Nurses ( AACN ) has published " AACN Standards for Appropriate Staffing in Adult Critical Care ," the specialty's first, action-oriented staffing standards.
  • Appropriate staffing has long been one of the "AACN Standards for Establishing and Sustaining Healthy Work Environments" ( HWE standards ), first published in 2005.
  • Developed by a work group with representatives from a variety of nursing roles, "AACN Standards for Appropriate Staffing in Adult Critical Care" outlines seven standards to incorporate appropriate staffing into everyday operations and patient care.
  • In addition to the HWE standards and staffing standards, AACN has published guidelines specific to clinical nurse specialists, acute care nurse practitioners, tele-critical care nurses, and progressive care and critical care nurses.

Nurse Well-Being the Focus of Engage, Powered By ENA-Golisano Children's Hospital Partnership

Retrieved on: 
tisdag, april 23, 2024
Critical care, CEN, MSN, Hospital, Emergency nursing, Golisano Children's Hospital, Emergency Nurses Association, Partnership, Environment, Nursing, Patient, RN, Emergency, EDS, ENA

SCHAUMBURG, Ill., April 23, 2024 /PRNewswire/ -- Engage, Powered by ENA, on Tuesday announced a new partnership with Golisano Children's Hospital of Southwest Florida's emergency department that centers on enhancing the well-being and professional growth of emergency nurses who play an integral role in the care of pediatric patients.

Key Points: 
  • Engage, a subsidiary of the Emergency Nurses Association, launched in 2023 with a mission to elevate emergency nursing excellence through healthy and safe workplaces.
  • To accomplish that, Engage partnered with 25 EDs across the country, including Golisano, during its first year.
  • "Engage's goal is to empower these dedicated professionals by providing them with the resources and support they need to excel in pediatric emergency care."
  • "We aim to ensure our nurses feel valued, heard and supported so they can excel in their roles," Callender added.

NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US

Retrieved on: 
fredag, april 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Silicon, Patent, VCS, Division

The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.

Key Points: 
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • A joint abstract by Dr. Low and Dr. Hawking featuring Dr. Hawking’s brain patterns analyzed by NeuroVigil’s technology was released as early as 2012.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.

CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US

Retrieved on: 
fredag, april 5, 2024
Head, Roche, MIT Technology Review, IP, FCCP, Clinic, Seed, Consciousness, Partnership, Novartis, SAN, DNA, Aneurysm, Critical care, Stanford School, Cedars-Sinai Medical Center, Lawyer, Harvard Medical School, DSS, University, MD, Hospital, FDA, Apnea, Brain, ALS, MIT, Neocortex, Biomarker, Bird, Doctor of Philosophy, Human, Brain tumor, BCIS, Patent, VCS, Division

“Who needs implants when you have the real deal?” said Dr. Philip Low, PhD, NeuroVigil’s Chairman, Chief Executive and Technology Officer, Founder and Supermajority Owner.

Key Points: 
  • “Who needs implants when you have the real deal?” said Dr. Philip Low, PhD, NeuroVigil’s Chairman, Chief Executive and Technology Officer, Founder and Supermajority Owner.
  • The investigators will initially not be allowed to modify anyone’s therapy based on iBrain data.
  • The technology was also successfully demonstrated on ALS sufferer Augie Nieto in 2013 who spelled “COMMUNICATE” with his mind.
  • In the past two years, NeuroVigil has recruited talent from Amgen, Roche, Novartis and MIT in preparation for the launch.